机构：[1]State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Sichuan, Chengdu 610041, China四川大学华西医院[2]Department of Pharmacy, West China Hospital of Sichuan University, Chengdu 610041, China四川大学华西医院[3]West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children Sichuan University, Ministry of Education, Chengdu, Sichuan Province, China[4]Key Laboratory of Bioactive Peptides of Yunnan Province/Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences, KIZCUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Center for Biosafety Mega-Science, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China[5]Medical Research Center, The Affiliated Hospital of Southwest Jiaotong University, The Third People’s Hospital of Chengdu, The Second Chengdu Hospital Affiliated to Chongqing Medical University, Chengdu 610504, China
National Key Program of China during the 12th Five-Year Plan Period (Grant 2012ZX09103101-022, 2012ZX10001-006, 2014ZX10005-002), the National Natural Science Foundation of China (81773195, 82060670), Science and Technology Department of Sichuan Province of China (2021YJ0220) and Institutional Research Fund from Sichuan University (2022SCUH0047), Yunnan Key Research and Development Program (202103AC100005), Sichuan Science and Technology Program (No. 2023YFH0097).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类|4 区医学
小类|2 区有机化学4 区药物化学
第一作者：
第一作者机构：[1]State Key Laboratory of Biotherapy, Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital of Sichuan University, Sichuan, Chengdu 610041, China[2]Department of Pharmacy, West China Hospital of Sichuan University, Chengdu 610041, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Luo Dan,Luo Ronghua,Wang Weilin,et al.Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1[J].Bioorganic & Medicinal Chemistry Letters.2024,111:129880.doi:10.1016/j.bmcl.2024.129880.
APA：
Luo Dan,Luo Ronghua,Wang Weilin,Deng Rui,Wang Shirui...&Li Rui.(2024).Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1.Bioorganic & Medicinal Chemistry Letters,111,
MLA：
Luo Dan,et al."Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1".Bioorganic & Medicinal Chemistry Letters 111.(2024):129880
